Aldeyra Therapeutics Inc [NASDAQ: ALDX] closed the trading session at $4.84.
The stocks have a year to date performance of -3.01 percent and weekly performance of -2.02 percent. The stock has been moved at 25.06 percent over the last six months. The stock has performed -4.35 percent around the most recent 30 days and changed -12.95 percent over the most recent 3-months.
If compared to the average trading volume of 464.38K shares, ALDX reached to a volume of 274810 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Aldeyra Therapeutics Inc [ALDX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ALDX shares is $10.29 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ALDX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Aldeyra Therapeutics Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on April 03, 2024. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on April 02, 2024, representing the official price target for Aldeyra Therapeutics Inc stock. Previously, the target price had yet another raise to $15, while H.C. Wainwright analysts kept a Buy rating on ALDX stock.
The Average True Range (ATR) for Aldeyra Therapeutics Inc is set at 0.29 The Price to Book ratio for the last quarter was 3.39, with the Price to Cash per share for the same quarter was set at 1.22.
ALDX stock trade performance evaluation
Aldeyra Therapeutics Inc [ALDX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.02. With this latest performance, ALDX shares dropped by -4.35% in over the last four-week period, additionally plugging by 25.06% over the last 6 months – not to mention a rise of 51.25% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ALDX stock in for the last two-week period is set at 46.35, with the RSI for the last a single of trading hit 45.12, and the three-weeks RSI is set at 47.07 for Aldeyra Therapeutics Inc [ALDX]. The present Moving Average for the last 50 days of trading for this stock 4.97, while it was recorded at 4.82 for the last single week of trading, and 4.64 for the last 200 days.
Aldeyra Therapeutics Inc [ALDX]: An insightful look at the core fundamentals
Aldeyra Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.64 and a Current Ratio set at 6.64.
Aldeyra Therapeutics Inc [ALDX]: Institutional Ownership
There are presently around $62.10%, or 63.66%% of ALDX stock, in the hands of institutional investors. The top three institutional holders of ALDX stocks are: PERCEPTIVE ADVISORS LLC with ownership of 9.28 million shares, which is approximately 15.6121%. KNOLL CAPITAL MANAGEMENT, LLC, holding 5.48 million shares of the stock with an approximate value of $$18.12 million in ALDX stocks shares; and KNOLL CAPITAL MANAGEMENT, LLC, currently with $$12.39 million in ALDX stock with ownership which is approximately 6.2988%.
